Neon Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
01 Mar 2019	Form 3: Siegel Jolie, VP, General Counsel
07 Nov 2018	Form 3: Bazemore Robert B, Director No securities owned
26 Jun 2018	Form 3: Hadley Harbor Master Investors (Cayman) L.p., 10% owner
26 Jun 2018	Form 3: Third Rock Ventures III, L.p., 10% owner and 4 others Holds 400,000 shares of Common Stock
26 Jun 2018	Form 3: Kamen Robert, Director
26 Jun 2018	Form 3: Zausner Meryl, Director
26 Jun 2018	Form 3: Tepper Robert I, Director Holds 0 shares of Common Stock
26 Jun 2018	Form 3: Pfeffer Cary, Director Holds 0 shares of Common Stock
26 Jun 2018	Form 3: Sherwin Stephen A, Director Holds 45,000 shares of Common Stock
26 Jun 2018	Form 3: O'Dowd Hugh, Director Holds 427,000 shares of Common Stock
26 Jun 2018	Form 3: Lander Eric S, Director Holds 134,000 shares of Common Stock
26 Jun 2018	Form 3: Gaynor Richard, President of R&D Holds 89,322 shares of Common Stock
26 Jun 2018	Form 3: Ang Robert, Chief Business Officer Holds 259,525 shares of Common Stock
26 Jun 2018	Form 3: Adams Julian, Director
26 Jun 2018	Form 3: Al-Wakeel Yasir B., Chief Financial Officer
26 Jun 2018	Form 3: Access Industries Holdings Llc, 10% owner and 4 others

Comments